USPTO serial 79027489
ANCERIS
Reviewed by CopyMark Law Group
Reg. 3340217Status 404
- Filing date
- Status date
- Registration date
- Nov 20, 2007
- Examiner
- SMIGA, HOWARD
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ANCERIS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MARY MARGARET L. O'DONNELL
Mary Margaret L. O'Donnell BLUE FILAMENT LAW PLLC450 NORTH OLD WOODWARDFIRST FLOORBIRMINGHAM, MI 48009Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products and small molecules used in the manufacture and production of medicines, pharmaceutical, cosmetic and dermatological products | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical and veterinary products for use in the treatment of cancer, metabolic, immunologic, dermatologic, cardiologic, cardiovascular, inflammatory, ophthalmologic, neurologic, respirologic, rheumatologic diseases, infectious vascular diseases, endocrine diseases, diseases of the immune system, viruses, immunodeficiency, transplants, sclerosis, auto-immune disorders, colds, arthritis; sanitary products for medical purposes, namely, sanitary pads, sanitary napkins; chemical preparations for medical or pharmaceutical use, chemical preparations for veterinary use, chemical pharmaceuticals, namely, for sanitary care other than toiletries, vaccines; medicines for humans for use in the treatment of cancer, metabolic, immunologic, dermatologic, cardiologic, cardiovascular, inflammatory, ophthalmologic, neurologic, respirologic, rheumatologic diseases, infectious vascular diseases, endocrine diseases, diseases of the immune system, viruses, immunodeficiency, transplants, sclerosis, auto-immune disorders, colds, arthritis; medicines for veterinary use for use in the treatment of cancer, metabolic, immunologic, dermatologic, cardiologic, cardiovascular, inflammatory, ophthalmologic, neurologic, respirologic, rheumatologic diseases, infectious vascular diseases, endocrine diseases, diseases of the immune system, viruses, immunodeficiency, transplants, sclerosis, auto-immune disorders, colds, arthritis; therapeutic preparations for use in the treatment of cancer, metabolic, immunologic, dermatologic, cardiologic, cardiovascular, inflammatory, ophthalmologic, neurologic, respirologic, rheumatologic diseases, infectious vascular diseases, endocrine diseases, diseases of the immune system, viruses, immunodeficiency, transplants, sclerosis, auto-immune disorders, colds, arthritis | SECTION 71 - CANCELLED | — |
| 042 | Evaluations, assessments and research in the fields of medical science and pharmaceutical technology provided by engineers; chemical research, biological research, bacteriological research, cosmetic science research, chemical analyses, physics research, clinical studies, pharmaceutical research services | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 30, 2016 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Dec 30, 2016 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 24, 2015 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 7, 2015 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 7, 2015 | INPC | INVALIDATION PROCESSED | — |
| Feb 27, 2015 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 27, 2014 | C71T | CANCELLED SECTION 71 | — |
| Mar 11, 2013 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 13, 2011 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 13, 2011 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 5, 2009 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 28, 2008 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 28, 2008 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 20, 2008 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 20, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 4, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 15, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| May 25, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 25, 2007 | ALIE | ASSIGNED TO LIE | — |
| May 9, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 8, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 7, 2007 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 7, 2007 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 7, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 7, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 1, 2006 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 8, 2006 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 8, 2006 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 7, 2006 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 6, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 2, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 29, 2006 | NWAP | NEW APPLICATION ENTERED | — |
| Sep 28, 2006 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |